User profiles for Pablo Martinez-Camblor
Pablo Martínez-CamblorGeisel School of Medicine at Dartmouth Verified email at dartmouth.edu Cited by 10542 |
Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine
…, D Larrosa, C Ramón, J Vega, P Martínez-Camblor… - Neurology, 2013 - AAN Enterprises
Objective: To determine calcitonin gene-related peptide (CGRP) levels outside migraine
attacks in peripheral blood as a potential biomarker for chronic migraine (CM). Methods: …
attacks in peripheral blood as a potential biomarker for chronic migraine (CM). Methods: …
[HTML][HTML] Lung-function trajectories leading to chronic obstructive pulmonary disease
…, FD Martinez, P Martinez-Camblor… - … England Journal of …, 2015 - Mass Medical Soc
Background Chronic obstructive pulmonary disease (COPD) is thought to result from an
accelerated decline in forced expiratory volume in 1 second (FEV 1 ) over time. Yet it is possible …
accelerated decline in forced expiratory volume in 1 second (FEV 1 ) over time. Yet it is possible …
Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study
…, P Martínez-Camblor… - Nephrology Dialysis …, 2015 - academic.oup.com
Background Abnormalities in serum phosphorus, calcium and parathyroid hormone (PTH)
have been associated with poor survival in haemodialysis patients. This COSMOS (Current …
have been associated with poor survival in haemodialysis patients. This COSMOS (Current …
The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort
R Kohansal, P Martinez-Camblor, A Agustí… - American journal of …, 2009 - atsjournals.org
Rationale: Understanding normal lung development and aging in health and disease, both in
men and in women, is essential to interpreting any therapeutic intervention. Objectives: We …
men and in women, is essential to interpreting any therapeutic intervention. Objectives: We …
CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine
…, P Martínez‐Camblor… - … : The Journal of …, 2014 - Wiley Online Library
Background Onabotulinumtoxin type A (onabot A ) has shown efficacy in chronic migraine (
CM ). Its precise mechanism of action, however, is unknown. Objective To analyze a …
CM ). Its precise mechanism of action, however, is unknown. Objective To analyze a …
OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine
E Cernuda-Morollón, C Ramón, P Martínez-Camblor… - Pain, 2015 - journals.lww.com
OnabotulinumtoxinA (onabotA) has shown efficacy in chronic migraine (CM). Its mechanism
of action, however, remains obscure. We have analysed whether treatment with onabotA is …
of action, however, remains obscure. We have analysed whether treatment with onabotA is …
DNA methylation signatures identify biologically distinct thyroid cancer subtypes
…, P Martínez-Camblor… - The Journal of …, 2013 - academic.oup.com
Objective: The purpose of this study was to determine the global patterns of aberrant DNA
methylation in thyroid cancer. Research Design and Methods: We have used DNA methylation …
methylation in thyroid cancer. Research Design and Methods: We have used DNA methylation …
Circulating inflammatory miRNA signature in response to different doses of aerobic exercise
…, SMA Soares, P Martínez-Camblor… - Journal of applied …, 2015 - journals.physiology.org
While moderate acute exercise has been associated with strong anti-inflammatory
mechanisms, strenuous exercise has been linked to deleterious inflammatory perturbations. It is …
mechanisms, strenuous exercise has been linked to deleterious inflammatory perturbations. It is …
Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry
T Bernal, P Martínez-Camblor, J Sánchez-García… - Leukemia, 2015 - nature.com
The benefit of azacitidine treatment in survival of high-risk myelodysplastic syndromes (MDS)
patients compared with conventional care treatment (CCT) has not been established …
patients compared with conventional care treatment (CCT) has not been established …
Plasma circular RNA hsa_circ_0001445 and coronary artery disease: Performance as a biomarker
D Vilades, P Martínez-Camblor, A Ferrero-Gregori… - 2020 - digital.csic.es
The role of circular RNAs (circRNAs) as biomarkers remains poorly characterized. Here, we
investigated the performance of the circRNA hsa_circ_0001445 as a biomarker of coronary …
investigated the performance of the circRNA hsa_circ_0001445 as a biomarker of coronary …